Latest news
Arcutis Biotherapeutics (ARQT) Could Be 31% Undervalued Following Profit And Higher Guidance - simplywall.stsimplywall.st · Sun, 09 Aug 2026 16:29:46 GMTARQT Technical Analysis & Stock Price Forecast - Intellectia AIIntellectia AI · Sat, 08 Aug 2026 21:10:21 GMTArcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 20:05:55 GMT24 New Arcutis Employees Get Stock Awards That Vest Over Four Years - Stock TitanStock Titan · Fri, 07 Aug 2026 20:00:00 GMTState Street Corporation (ARQT) discloses 4.7% beneficial stake in Arcutis - Stock TitanStock Titan · Fri, 07 Aug 2026 12:43:03 GMTArcutis Biotherapeutics (ARQT) Stock Profit Turn Faces ZORYVE Concentration Question - simplywall.stsimplywall.st · Fri, 07 Aug 2026 04:51:16 GMTArcutis Biotherapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ARQT) 2026-08-06 - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 17:01:27 GMTDid Profitability, Higher 2026 Guidance, and New Commercial Leadership Just Recast Arcutis Biotherapeutics' (ARQT) Investment Narrative? - simplywall.stsimplywall.st · Thu, 06 Aug 2026 15:40:40 GMT